Yu Wang

Dr. Yu Wang

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2023 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
WZWeian Zhu
Weian Zhu
HZHengda Zeng
Hengda Zeng
JHJiongduan Huang
Jiongduan Huang
JWJianjie Wu
Jianjie Wu
YWYu Wang
Yu Wang
WLWenjie Lai
Wenjie Lai
Background: Prostate cancer (PCa), a globally prevalent malignancy, displays intricate heterogeneity within its epithelial cells, closely linked with disease progression and immune modulation. However, the clinical significance of genes and biomarkers associated with these cells remains inadequately explored. To address this gap, this study aimed to comprehensively investigate the roles and clinical value of epithelial cell-related genes in PCa. Methods: Leveraging single-cell sequencing data from GSE176031, we conducted an extensive analysis to identify epithelial cell marker genes (ECMGs). Employing consensus clustering analysis, we evaluated the correlations between ECMGs, prognosis, and immune responses in PCa. Subsequently, we developed and validated an optimal prognostic signature, termed the epithelial cell marker gene prognostic signature (ECMGPS), through synergistic analysis from 101 models employing 10 machine learning algorithms across five independent cohorts. Additionally, we collected clinical features and previously published signatures from the literature for comparative analysis. Furthermore, we explored the clinical utility of ECMGPS in immunotherapy and drug selection using multi-omics analysis and the IMvigor cohort. Finally, we investigated the biological functions of the hub gene, transmembrane p24 trafficking protein 3 (TMED3), in PCa using public databases and experiments. Results: We identified a comprehensive set of 543 ECMGs and established a strong correlation between ECMGs and both the prognostic evaluation and immune classification in PCa. Notably, ECMGPS exhibited robust predictive capability, surpassing traditional clinical features and 80 published signatures in terms of both independence and accuracy across five cohorts. Significantly, ECMGPS demonstrated significant promise in identifying potential PCa patients who might benefit from immunotherapy and personalized medicine, thereby moving us nearer to tailored therapeutic approaches for individuals. Moreover, the role of TMED3 in promoting malignant proliferation of PCa cells was validated. Conclusions: Our findings highlight ECMGPS as a powerful tool for improving PCa patient outcomes and supply a robust conceptual framework for in-depth examination of PCa complexities. Simultaneously, our study has the potential to develop a novel alternative for PCa diagnosis and prognostication.

1 May 2020 in International Journal of Mechanical Sciences
Verified
Journal Article
Closed access
YWYu Wang
Yu Wang
QLQ.M. Li
Q.M. Li
YXYuyang Xing
Yuyang Xing

1 January 2017 in Mechanical Systems and Signal Processing
Verified
Journal Article
Closed access
JWJing Wu
Jing Wu
YWYu Wang
Yu Wang
WZWeiwei Zhang
Weiwei Zhang
ZNZhenhua Nie
Zhenhua Nie
RLRong Lin
Rong Lin
HMHongwei Ma
Hongwei Ma

1 May 2021 in European Journal of Mechanics - A/Solids
Verified
Journal Article
Closed access
Chengxing YangChengxing Yang
Chengxing Yang
QLQ.M. Li
Q.M. Li
YWYu Wang
Yu Wang

1 August 2023 in Journal of Materials Chemistry A
Verified
Journal Article
Closed access
PDF file
YWYu Wang
Yu Wang
SZSongyao Zhang
Songyao Zhang
HWHaoqiang Wang
Haoqiang Wang
YWYi Wang
Yi Wang
YLYani Liu
Yani Liu
QYQunhui Yuan
Qunhui Yuan
A theoretically guided Zn2+confining–anchoring strategy is proposed based on the different strengths between alpha-cyclodextrin (α-CD) additives and various crystallographic planes of zinc to achieve dendrite-free aqueous ZIB.

25 September 2024 in Nano Energy
Verified
Journal Article
Closed access
ALAnxin Luo
Anxin Luo
SGShanghao Gu
Shanghao Gu
XGXinge Guo
Xinge Guo
WXWeihan Xu
Weihan Xu
YWYu Wang
Yu Wang
FWFei Wang
Fei Wang